As of 2025-09-17, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (3.87) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.49 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -359.7%.
The range of the Relative Valuation is (3.18) - (4.51) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 10.6x | 8.8x |
| Forward P/E multiples | 7.4x - 11.2x | 9.3x |
| Fair Price | (3.18) - (4.51) | (3.87) |
| Upside | -313.5% - -403.0% | -359.7% |
| Date | P/E |
| 2025-09-15 | -3.49 |
| 2025-09-12 | -3.53 |
| 2025-09-11 | -3.46 |
| 2025-09-10 | -3.51 |
| 2025-09-09 | -3.39 |
| 2025-09-08 | -3.44 |
| 2025-09-05 | -3.60 |
| 2025-09-04 | -3.58 |
| 2025-09-03 | -3.53 |
| 2025-09-02 | -3.56 |
| 2025-08-29 | -3.49 |
| 2025-08-28 | -3.53 |
| 2025-08-27 | -3.65 |
| 2025-08-26 | -3.70 |
| 2025-08-25 | -3.74 |
| 2025-08-22 | -3.79 |
| 2025-08-21 | -3.79 |
| 2025-08-20 | -3.74 |
| 2025-08-19 | -3.67 |
| 2025-08-18 | -3.95 |
| 2025-08-15 | -4.28 |
| 2025-08-14 | -4.33 |
| 2025-08-13 | -3.58 |
| 2025-08-12 | -3.60 |
| 2025-08-11 | -3.27 |
| 2025-08-08 | -3.27 |
| 2025-08-07 | -3.46 |
| 2025-08-06 | -3.46 |
| 2025-08-05 | -4.33 |
| 2025-08-01 | -4.47 |
| 2025-07-31 | -4.82 |
| 2025-07-30 | -4.87 |
| 2025-07-29 | -4.70 |
| 2025-07-28 | -4.91 |
| 2025-07-25 | -4.58 |
| 2025-07-24 | -4.49 |
| 2025-07-23 | -4.56 |
| 2025-07-22 | -4.40 |
| 2025-07-21 | -3.91 |
| 2025-07-18 | -3.77 |
| 2025-07-17 | -3.77 |
| 2025-07-16 | -4.12 |
| 2025-07-15 | -4.07 |
| 2025-07-14 | -4.23 |
| 2025-07-11 | -4.21 |
| 2025-07-10 | -4.35 |
| 2025-07-09 | -4.40 |
| 2025-07-08 | -4.44 |
| 2025-07-07 | -4.61 |
| 2025-07-04 | -4.84 |